• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

Purpose of review The objective of this review is to provide the reader with a synopsis of
percutaneous alcohol septal ablation (ASA) as an effective and time-honored treatment …

Alcohol septal ablation (ASA) is a well-established procedure for septal reduction therapy in
patients with obstructive hypertrophic cardiomyopathy, significant at rest or provocable …

Background It is still unclear whether there is a sex difference in the prognosis of patients
with hypertrophic cardiomyopathy (HCM). Therefore, we performed a meta‐analysis to …

Although obesity is associated with increased phenotypic expression in patients with
hypertrophic cardiomyopathy (HC), the effect of body mass index (BMI) on in-hospital …

Objective To evaluate sex-associated differences in the short-and long-term outcomes of
patients with hypertrophic cardiomyopathy (HCM) undergoing septal myectomy and alcohol …

Background There is a paucity of data on sex differences in outcomes after surgical
myectomy (SM) for hypertrophic cardiomyopathy (HCM). Methods Patients who received SM …

There are no national data on age-based outcomes of septal reduction therapy. Using the
National Inpatient Sample, we included all adult patients who underwent septal myectomy …

Background There is limited data examining potential sex-based disparities in the utilization
and complications of septal reduction therapy (SRT) in patients with obstructive hypertrophic …

Hypertrophic obstructive cardiomyopathy (HOCM) is currently treated with septal reduction
therapy in severely symptomatic patients who are not responsive to medical treatment. Since …